Roles of HIV-1 capsid in viral replication and immune evasion

Virus Research

Volumn 193, Issue , 2014, Pages 116-129

  Le Sage, Valerie ^a,b   Mouland, Andrew J ^a,b   Valiente Echeverría, Fernando ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Capsid (CA); Human immunodeficiency virus type 1 (HIV 1); Innate immune evasion; Nuclear import; Stress granules; Virus host interactions

Indexed keywords

CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 6; CYCLOPHILIN A; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; NUP153 PROTEIN; NUP358 PROTEIN; PDZ DOMAIN CONTAINING PROTEIN 8; PDZ PROTEIN; PEPTIDYLPROLYL ISOMERASE PIN1; TNPO3 PROTEIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; CAPSID PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; INNATE IMMUNITY; LIFE CYCLE; NONHUMAN; NUCLEAR IMPORT; PROTEIN PROTEIN INTERACTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS REPLICATION; ACTIVE TRANSPORT; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS DNA CELL DNA INTERACTION; VIRUS UNCOATING;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

ACTIVE TRANSPORT, CELL NUCLEUS; CAPSID; CAPSID PROTEINS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; VIRUS INTEGRATION; VIRUS INTERNALIZATION; VIRUS REPLICATION; VIRUS UNCOATING;

EID: 84914161611     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.07.010     Document Type: Article

References (254)

1. Aberham C., Weber S., Phares W. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J. Virol. 1996, 70(6):3536-3544.
2. Abrahamyan L.G., Chatel-Chaix L., Ajamian L., Milev M.P., Monette A., Clement J.F., Song R., Lehmann M., DesGroseillers L., Laughrea M., Boccaccio G., Mouland A.J. Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA. J. Cell Sci. 2010, 123(Pt 3):369-383.
3. Acheampong E.A., Roschel C., Mukhtar M., Srinivasan A., Rafi M., Pomerantz R.J., Parveen Z. Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis. Virol. J. 2009, 6:183.
4. Adamson C.S., Freed E.O. Novel approaches to inhibiting HIV-1 replication. Antiviral Res. 2010, 85(1):119-141.
5. Ambrose Z., Aiken C. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. Virology 2014.
6. Ambrose Z., Lee K., Ndjomou J., Xu H., Oztop I., Matous J., Takemura T., Unutmaz D., Engelman A., Hughes S.H., KewalRamani V.N. Human immunodeficiency virus type 1 capsid mutation N74D alters cyclophilin A dependence and impairs macrophage infection. J. Virol. 2012, 86(8):4708-4714.
7. An P., Wang L.H., Hutcheson-Dilks H., Nelson G., Donfield S., Goedert J.J., Rinaldo C.R., Buchbinder S., Kirk G.D., O'Brien S.J., Winkler C.A. Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog. 2007, 3(6):e88.
8. Ao Z., Fowke K.R., Cohen E.A., Yao X. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology 2005, 2:62.
9. Ao Z., Huang G., Yao H., Xu Z., Labine M., Cochrane A.W., Yao X. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J. Biol. Chem. 2007, 282(18):13456-13467.
10. Ao Z., Yao X., Cohen E.A. Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system. J. Virol. 2004, 78(6):3170-3177.
11. Arfi V., Lienard J., Nguyen X.N., Berger G., Rigal D., Darlix J.L., Cimarelli A. Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection. J. Virol. 2009, 83(15):7524-7535.
12. Arhel N., Munier S., Souque P., Mollier K., Charneau P. Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type. J. Virol. 2006, 80(20):10262-10269.
13. Arhel N.J., Souquere-Besse S., Munier S., Souque P., Guadagnini S., Rutherford S., Prevost M.C., Allen T.D., Charneau P. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 2007, 26(12):3025-3037.
14. Asaoka K., Ikeda K., Hishinuma T., Horie-Inoue K., Takeda S., Inoue S. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem. Biophys. Res. Commun. 2005, 338(4):1950-1956.
15. Auewarakul P., Wacharapornin P., Srichatrapimuk S., Chutipongtanate S., Puthavathana P. Uncoating of HIV-1 requires cellular activation. Virology 2005, 337(1):93-101.
16. Bastos R., Lin A., Enarson M., Burke B. Targeting and function in mRNA export of nuclear pore complex protein Nup153. J. Cell Biol. 1996, 134(5):1141-1156.
17. Bayro M.J., Chen B., Yau W.M., Tycko R. Site-specific structural variations accompanying tubular assembly of the HIV-1 capsid protein. J. Mol. Biol. 2014, 426(5):1109-1127.
18. Bell N.M., Lever A.M. HIV Gag polyprotein: processing and early viral particle assembly. Trends Microbiol. 2013, 21(3):136-144.
19. Berthet-Colominas C., Monaco S., Novelli A., Sibai G., Mallet F., Cusack S. Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab. EMBO J. 1999, 18(5):1124-1136.
20. Biancotto A., Iglehart S.J., Vanpouille C., Condack C.E., Lisco A., Ruecker E., Hirsch I., Margolis L.B., Grivel J.C. HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood 2008, 111(2):699-704.
21. Bichel K., Price A.J., Schaller T., Towers G.J., Freund S.M., James L.C. HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology 2013, 10:81.
22. Bieniasz P.D. The cell biology of HIV-1 virion genesis. Cell Host Microbe 2009, 5(6):550-558.
23. Biris N., Tomashevski A., Bhattacharya A., Diaz-Griffero F., Ivanov D.N. Rhesus monkey TRIM5alpha SPRY domain recognizes multiple epitopes that span several capsid monomers on the surface of the HIV-1 mature viral core. J. Mol. Biol. 2013, 425(24):5032-5044.
24. Biris N., Yang Y., Taylor A.B., Tomashevski A., Guo M., Hart P.J., Diaz-Griffero F., Ivanov D.N. Structure of the rhesus monkey TRIM5alpha PRYSPRY domain, the HIV capsid recognition module. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(33):13278-13283.
25. Blair W.S., Pickford C., Irving S.L., Brown D.G., Anderson M., Bazin R., Cao J., Ciaramella G., Isaacson J., Jackson L., Hunt R., Kjerrstrom A., Nieman J.A., Patick A.K., Perros M., Scott A.D., Whitby K., Wu H., Butler S.L. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 2010, 6(12):e1001220.
26. Bosco D.A., Eisenmesser E.Z., Pochapsky S., Sundquist W.I., Kern D. Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(8):5247-5252.
27. Bouamr F., Scarlata S., Carter C. Role of myristylation in HIV-1 Gag assembly. Biochemistry 2003, 42(21):6408-6417.
28. Braaten D., Ansari H., Luban J. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 1997, 71(3):2107-2113.
29. Braaten D., Franke E.K., Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 1996, 70(6):3551-3560.
30. Brandariz-Nunez A., Roa A., Valle-Casuso J.C., Biris N., Ivanov D., Diaz-Griffero F. Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5alpha. Virology 2013, 435(2):463-471.
31. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926.
32. Briggs J.A., Riches J.D., Glass B., Bartonova V., Zanetti G., Krausslich H.G. Structure and assembly of immature HIV. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(27):11090-11095.
33. Briggs J.A., Wilk T., Welker R., Krausslich H.G., Fuller S.D. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 2003, 22(7):1707-1715.
34. Bukrinsky M.I., Haggerty S., Dempsey M.P., Sharova N., Adzhubel A., Spitz L., Lewis P., Goldfarb D., Emerman M., Stevenson M. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993, 365(6447):666-669.
35. Burniston M.T., Cimarelli A., Colgan J., Curtis S.P., Luban J. Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J. Virol. 1999, 73(10):8527-8540.
36. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., Konig R., Bandyopadhyay S., Ideker T., Goff S.P., Krogan N.J., Frankel A.D., Young J.A., Chanda S.K. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5(5):e1000437.
37. Byeon I.J., Meng X., Jung J., Zhao G., Yang R., Ahn J., Shi J., Concel J., Aiken C., Zhang P., Gronenborn A.M. Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 2009, 139(4):780-790.
38. Camacho R., Teofilo E. Antiretroviral therapy in treatment-naive patients with HIV infection. Curr. Opin. HIV AIDS 2011, 6(Suppl. 1):S3L 11.
39. Cartier C., Sivard P., Tranchat C., Decimo D., Desgranges C., Boyer V. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J. Biol. Chem. 1999, 274(27):19434-19440.
40. Castello A., Franco D., Moral-Lopez P., Berlanga J.J., Alvarez E., Wimmer E., Carrasco L. HIV-1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. PLoS ONE 2009, 4(11):e7997.
41. Chowdhury D., Beresford P.J., Zhu P., Zhang D., Sung J.S., Demple B., Perrino F.W., Lieberman J. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Mol. Cell 2006, 23(1):133-142.
42. Christ F., Thys W., De Rijck J., Gijsbers R., Albanese A., Arosio D., Emiliani S., Rain J.C., Benarous R., Cereseto A., Debyser Z. Transportin-SR2 imports HIV into the nucleus. Curr. Biol. 2008, 18(16):1192-1202.
43. Cimarelli A., Sandin S., Hoglund S., Luban J. Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation. J. Virol. 2000, 74(9):4273-4283.
44. Colgan J., Yuan H.E., Franke E.K., Luban J. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 1996, 70(7):4299-4310.
45. Cooper A., Garcia M., Petrovas C., Yamamoto T., Koup R.A., Nabel G.J. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 2013, 498(7454):376-379.
46. Danielson C.M., Cianci G.C., Hope T.J. Recruitment and dynamics of proteasome association with rhTRIM5alpha cytoplasmic complexes during HIV-1 infection. Traffic 2012, 13(9):1206-1217.
47. De Iaco A., Luban J. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. Retrovirology 2011, 8:98.
48. De Iaco A., Luban J. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. Retrovirology 2014, 11:11.
49. De Iaco A., Santoni F., Vannier A., Guipponi M., Antonarakis S., Luban J. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology 2013, 10:20.
50. Depienne C., Mousnier A., Leh H., Le Rouzic E., Dormont D., Benichou S., Dargemont C. Characterization of the nuclear import pathway for HIV-1 integrase. J. Biol. Chem. 2001, 276(21):18102-18107.
51. Deshmukh L., Schwieters C.D., Grishaev A., Ghirlando R., Baber J.L., Clore G.M. Structure and dynamics of full-length HIV-1 capsid protein in solution. J. Am. Chem. Soc. 2013, 135(43):16133-16147.
52. Di Marzio P., Choe S., Ebright M., Knoblauch R., Landau N.R. Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 1995, 69(12):7909-7916.
53. Di Nunzio F., Danckaert A., Fricke T., Perez P., Fernandez J., Perret E., Roux P., Shorte S., Charneau P., Diaz-Griffero F., Arhel N.J. Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration. PLoS ONE 2012, 7(9):e46037.
54. Di Nunzio F., Fricke T., Miccio A., Valle-Casuso J.C., Perez P., Souque P., Rizzi E., Severgnini M., Mavilio F., Charneau P., Diaz-Griffero F. Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology 2013, 440(1):8-18.
55. Diaz-Griffero F. Caging the beast: TRIM5alpha binding to the HIV-1 core. Viruses 2011, 3(5):423-428.
56. Diaz-Griffero F. The role of TNPO3 in HIV-1 replication. Mol. Biol. Int. 2012, 2012:868597.
57. Dismuke D.J., Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 2006, 80(8):3712-3720.
58. Dochi T., Nakano T., Inoue M., Takamune N., Shoji S., Sano K., Misumi S. Phosphorylation of human immunodeficiency virus type 1 (HIV-1) capsid protein at serine 16, required for peptidyl-prolyl isomerase (Pin1)-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2 (ERK2). J. Gen. Virol. 2014, 95(5):1156-1166.
59. Doitsh G., Cavrois M., Lassen K.G., Zepeda O., Yang Z., Santiago M.L., Hebbeler A.M., Greene W.C. Abortive HIV infection mediates CD4T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143(5):789-801.
60. Doitsh G., Galloway N.L., Geng X., Yang Z., Monroe K.M., Zepeda O., Hunt P.W., Hatano H., Sowinski S., Munoz-Arias I., Greene W.C. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 2014, 505(7484):509-514.
61. Dorfman T., Weimann A., Borsetti A., Walsh C.T., Gottlinger H.G. Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions. J. Virol. 1997, 71(9):7110-7113.
62. Du S., Betts L., Yang R., Shi H., Concel J., Ahn J., Aiken C., Zhang P., Yeh J.I. Structure of the HIV-1 full-length capsid protein in a conformationally trapped unassembled state induced by small-molecule binding. J. Mol. Biol. 2011, 406(3):371-386.
63. Eckstein D.A., Penn M.L., Korin Y.D., Scripture-Adams D.D., Zack J.A., Kreisberg J.F., Roederer M., Sherman M.P., Chin P.S., Goldsmith M.A. HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 2001, 15(4):671-682.
64. Enarson P., Enarson M., Bastos R., Burke B. Amino-terminal sequences that direct nucleoporin nup153 to the inner surface of the nuclear envelope. Chromosoma 1998, 107(4):228-236.
65. Fahrenkrog B., Maco B., Fager A.M., Koser J., Sauder U., Ullman K.S., Aebi U. Domain-specific antibodies reveal multiple-site topology of Nup153 within the nuclear pore complex. J. Struct. Biol. 2002, 140(1-3):254-267.
66. Farnet C.M., Haseltine W.A. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 1991, 65(4):1910-1915.
67. Fassati A. HIV infection of non-dividing cells: a divisive problem. Retrovirology 2006, 3:74.
68. Fassati A. Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res. 2012, 170(1-2):15-24.
69. Fassati A., Goff S.P. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 2001, 75(8):3626-3635.
70. Fassati A., Gorlich D., Harrison I., Zaytseva L., Mingot J.M. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J. 2003, 22(14):3675-3685.
71. Ferguson B.J., Mansur D.S., Peters N.E., Ren H., Smith G.L. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. eLife 2012, 1:e00047.
72. Fink S.L., Cookson B.T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 2005, 73(4):1907-1916.
73. Forshey B.M., von Schwedler U., Sundquist W.I., Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 2002, 76(11):5667-5677.
74. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372(6504):359-362.
75. Fricke T., Valle-Casuso J.C., White T.E., Brandariz-Nunez A., Bosche W.J., Reszka N., Gorelick R., Diaz-Griffero F. The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6. Retrovirology 2013, 10:46.
76. Gallay P., Hope T., Chin D., Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(18):9825-9830.
77. Gamble T.R., Vajdos F.F., Yoo S., Worthylake D.K., Houseweart M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 1996, 87(7):1285-1294.
78. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., Hill C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278(5339):849-853.
79. Ganser-Pornillos B.K., Chandrasekaran V., Pornillos O., Sodroski J.G., Sundquist W.I., Yeager M. Hexagonal assembly of a restricting TRIM5alpha protein. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(2):534-539.
80. Ganser-Pornillos B.K., Cheng A., Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 2007, 131(1):70-79.
81. Ganser B.K., Li S., Klishko V.Y., Finch J.T., Sundquist W.I. Assembly and analysis of conical models for the HIV-1 core. Science 1999, 283(5398):80-83.
82. Gao D., Wu J., Wu Y.T., Du F., Aroh C., Yan N., Sun L., Chen Z.J. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013, 341(6148):903-906.
83. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., Korber B. Diversity considerations in HIV-1 vaccine selection. Science 2002, 296(5577):2354-2360.
84. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 1996, 273(5272):231-235.
85. Gordon H., Ajamian L., Valiente-Echeverria F., Levesque K., Rigby W.F., Mouland A.J. Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA. RNA Biol. 2013, 10(11):1714-1725.
86. Goujon C., Jarrosson-Wuilleme L., Bernaud J., Rigal D., Darlix J.L., Cimarelli A. With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther. 2006, 13(12):991-994.
87. Goujon C., Moncorge O., Bauby H., Doyle T., Ward C.C., Schaller T., Hue S., Barclay W.S., Schulz R., Malim M.H. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013, 502(7472):559-562.
88. Granelli-Piperno A., Golebiowska A., Trumpfheller C., Siegal F.P., Steinman R.M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(20):7669-7674.
89. Gross I., Hohenberg H., Krausslich H.G. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 1997, 249(2):592-600.
90. Guth C.A., Sodroski J. Contribution of PDZD8 to stabilization of the human immunodeficiency virus (HIV-1) capsid. J. Virol. 2014.
91. Haller O., Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 2011, 31(1):79-87.
92. Hatziioannou T., Perez-Caballero D., Cowan S., Bieniasz P.D. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J. Virol. 2005, 79(1):176-183.
93. Hearps A.C., Jans D.A. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism. Biochem. J. 2006, 398(3):475-484.
94. Heinzinger N.K., Bukinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(15):7311-7315.
95. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011, 25(5):679-689.
96. Henning M.S., Dubose B.N., Burse M.J., Aiken C., Yamashita M. In vivo functions of CPSF6 for HIV-1 as revealed by HIV-1 capsid evolution in HLA-B27-positive subjects. PLoS Pathog. 2014, 10(1):e1003868.
97. Henning M.S., Morham S.G., Goff S.P., Naghavi M.H. PDZD8 is a novel Gag-interacting factor that promotes retroviral infection. J. Virol. 2010, 84(17):8990-8995.
98. Henning M.S., Stiedl P., Barry D.S., McMahon R., Morham S.G., Walsh D., Naghavi M.H. PDZD8 is a novel moesin-interacting cytoskeletal regulatory protein that suppresses infection by herpes simplex virus type 1. Virology 2011, 415(2):114-121.
99. Hilditch L., Towers G.J. A model for cofactor use during HIV-1 reverse transcription and nuclear entry. Curr. Opin. Virol. 2014, 4C:32-36.
100. Hori T., Takeuchi H., Saito H., Sakuma R., Inagaki Y., Yamaoka S. A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly. J. Virol. 2013, 87(13):7726-7736.
101. Hornung V., Ablasser A., Charrel-Dennis M., Bauernfeind F., Horvath G., Caffrey D.R., Latz E., Fitzgerald K.A. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009, 458(7237):514-518.
102. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474(7353):658-661.
103. Hulme A.E., Perez O., Hope T.J. Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(24):9975-9980.
104. Isaguliants M., Smirnova O., Ivanov A.V., Kilpelainen A., Kuzmenko Y., Petkov S., Latanova A., Krotova O., Engstrom G., Karpov V., Kochetkov S., Wahren B., Starodubova E. Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization. Hum. Vaccines Immunother. 2013, 9(10):2111-2119.
105. Jacquot G., Le Rouzic E., David A., Mazzolini J., Bouchet J., Bouaziz S., Niedergang F., Pancino G., Benichou S. Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages. Retrovirology 2007, 4:84.
106. Jao C.Y., Salic A. Exploring RNA transcription and turnover in vivo by using click chemistry. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(41):15779-15784.
107. Jayappa K.D., Ao Z., Yang M., Wang J., Yao X. Identification of critical motifs within HIV-1 integrase required for importin alpha3 interaction and viral cDNA nuclear import. J. Mol. Biol. 2011, 410(5):847-862.
108. Jayappa K.D., Ao Z., Yao X. The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration. Int. J. Biochem. Mol. Biol. 2012, 3(1):70-85.
109. Jenkins Y., McEntee M., Weis K., Greene W.C. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 1998, 143(4):875-885.
110. Ji J.P., Loeb L.A. Fidelity of HIV-1 reverse transcriptase copying RNA in vitro. Biochemistry 1992, 31(4):954-958.
111. Jiang J., Ablan S.D., Derebail S., Hercik K., Soheilian F., Thomas J.A., Tang S., Hewlett I., Nagashima K., Gorelick R.J., Freed E.O., Levin J.G. The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability. Virology 2011, 421(2):253-265.
112. Kane M., Yadav S.S., Bitzegeio J., Kutluay S.B., Zang T., Wilson S.J., Schoggins J.W., Rice C.M., Yamashita M., Hatziioannou T., Bieniasz P.D. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013, 502(7472):563-566.
113. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B. mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(2):637-642.
114. Karageorgos L., Li P., Burrell C. Characterization of HIV replication complexes early after cell-to-cell infection. AIDS Res. Hum. Retroviruses 1993, 9(9):817-823.
115. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Reis e Sousa C., Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441(7089):101-105.
116. Katz R.A., Greger J.G., Skalka A.M. Effects of cell cycle status on early events in retroviral replication. J. Cell. Biochem. 2005, 94(5):880-889.
117. Keating S.E., Baran M., Bowie A.G. Cytosolic DNA sensors regulating type I interferon induction. Trends Immunol. 2011, 32(12):574-581.
118. Kedersha N., Chen S., Gilks N., Li W., Miller I.J., Stahl J., Anderson P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol. Biol. Cell 2002, 13(1):195-210.
119. Kelly B.N., Kyere S., Kinde I., Tang C., Howard B.R., Robinson H., Sundquist W.I., Summers M.F., Hill C.P. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J. Mol. Biol. 2007, 373(2):355-366.
120. Khorchid A., Halwani R., Wainberg M.A., Kleiman L. Role of RNA in facilitating Gag/Gag-Pol interaction. J. Virol. 2002, 76(8):4131-4137.
121. King M.C., Raposo G., Lemmon M.A. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(24):8957-8962.
122. Klumpp K., Crepin T. Capsid proteins of enveloped viruses as antiviral drug targets. Curr. Opin. Virol. 2014, 5C:63-71.
123. Koh Y., Wu X., Ferris A.L., Matreyek K.A., Smith S.J., Lee K., KewalRamani V.N., Hughes S.H., Engelman A. Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration. J. Virol. 2013, 87(1):648-658.
124. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135(1):49-60.
125. Kopito R.B., Elbaum M. Reversibility in nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(31):12743-12748.
126. Kramer A., Ludwig Y., Shahin V., Oberleithner H. A pathway separate from the central channel through the nuclear pore complex for inorganic ions and small macromolecules. J. Biol. Chem. 2007, 282(43):31437-31443.
127. Krishnan L., Matreyek K.A., Oztop I., Lee K., Tipper C.H., Li X., Dar M.J., Kewalramani V.N., Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J. Virol. 2010, 84(1):397-406.
128. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Segeral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474(7353):654-657.
129. Lahaye X., Satoh T., Gentili M., Cerboni S., Conrad C., Hurbain I., El Marjou A., Lacabaratz C., Lelievre J.D., Manel N. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013, 39(6):1132-1142.
130. Lamkanfi M., Dixit V.M. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 2010, 8(1):44-54.
131. Lammers M., Neumann H., Chin J.W., James L.C. Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization. Nat. Chem. Biol. 2010, 6(5):331-337.
132. Lamorte L., Titolo S., Lemke C.T., Goudreau N., Mercier J.F., Wardrop E., Shah V.B., von Schwedler U.K., Langelier C., Banik S.S., Aiken C., Sundquist W.I., Mason S.W. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Antimicrob. Agents Chemother. 2013, 57(10):4622-4631.
133. Le Douce V., Herbein G., Rohr O., Schwartz C. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 2010, 7:32.
134. Le Rouzic E., Mousnier A., Rustum C., Stutz F., Hallberg E., Dargemont C., Benichou S. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J. Biol. Chem. 2002, 277(47):45091-45098.
135. Le Sage V., Mouland A.J. Viral subversion of the nuclear pore complex. Viruses 2013, 5(8):2019-2042.
136. Lee B. HIV provides ample PAMPs for innate immune sensing. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(48):19183-19184.
137. Lee K., Ambrose Z., Martin T.D., Oztop I., Mulky A., Julias J.G., Vandegraaff N., Baumann J.G., Wang R., Yuen W., Takemura T., Shelton K., Taniuchi I., Li Y., Sodroski J., Littman D.R., Coffin J.M., Hughes S.H., Unutmaz D., Engelman A., KewalRamani V.N. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7(3):221-233.
138. Lee K., Mulky A., Yuen W., Martin T.D., Meyerson N.R., Choi L., Yu H., Sawyer S.L., Kewalramani V.N. HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J. Virol. 2012, 86(7):3851-3860.
139. Lewis P.F., Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 1994, 68(1):510-516.
140. Li G., Verheyen J., Rhee S.Y., Voet A., Vandamme A.M., Theys K. Functional conservation of HIV-1 Gag: implications for rational drug design. Retrovirology 2013, 10:126.
141. Li S., Hill C.P., Sundquist W.I., Finch J.T. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 2000, 407(6802):409-413.
142. Li X., Kim J., Song B., Finzi A., Pacheco B., Sodroski J. Virus-specific effects of TRIM5alpha(rh) RING domain functions on restriction of retroviruses. J. Virol. 2013, 87(13):7234-7245.
143. Li Y., Kar A.K., Sodroski J. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J. Virol. 2009, 83(21):10951-10962.
144. Li Y., Li X., Stremlau M., Lee M., Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J. Virol. 2006, 80(14):6738-6744.
145. Lienlaf M., Hayashi F., Di Nunzio F., Tochio N., Kigawa T., Yokoyama S., Diaz-Griffero F. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha. J. Virol. 2011, 85(17):8725-8737.
146. Lim R.Y., Huang N.P., Koser J., Deng J., Lau K.H., Schwarz-Herion K., Fahrenkrog B., Aebi U. Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(25):9512-9517.
147. Lin D.H., Zimmermann S., Stuwe T., Stuwe E., Hoelz A. Structural and functional analysis of the C-terminal domain of Nup358/RanBP2. J. Mol. Biol. 2013, 425(8):1318-1329.
148. Liu Z., Pan Q., Ding S., Qian J., Xu F., Zhou J., Cen S., Guo F., Liang C. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013, 14(4):398-410.
149. Lloyd R.E. How do viruses interact with stress-associated RNA granules?. PLoS Pathog. 2012, 8(6):e1002741.
150. Logue E.C., Taylor K.T., Goff P.H., Landau N.R. The cargo-binding domain of transportin 3 is required for lentivirus nuclear import. J. Virol. 2011, 85(24):12950-12961.
151. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73(6):1067-1078.
152. Lukic Z., Goff S.P., Campbell E.M., Arriagada G. Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5alpha-mediated restriction. Retrovirology 2013, 10:10.
153. Maertens G.N., Cook N.J., Wang W., Hare S., Gupta S.S., Oztop I., Lee K., Pye V.E., Cosnefroy O., Snijders A.P., Kewalramani V.N., Fassati A., Engelman A., Cherepanov P. Structural basis for nuclear import of splicing factors by human Transportin 3. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(7):2728-2733.
154. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448(7155):816-819.
155. Manel N., Hogstad B., Wang Y., Levy D.E., Unutmaz D., Littman D.R. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010, 467(7312):214-217.
156. Manocheewa S., Swain J.V., Lanxon-Cookson E., Rolland M., Mullins J.I. Fitness costs of mutations at the HIV-1 capsid hexamerization interface. PLoS ONE 2013, 8(6):e66065.
157. Matreyek K.A., Engelman A. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. J. Virol. 2011, 85(15):7818-7827.
158. Matreyek K.A., Yucel S.S., Li X., Engelman A. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog. 2013, 9(10):e1003693.
159. Mazroui R., Sukarieh R., Bordeleau M.E., Kaufman R.J., Northcote P., Tanaka J., Gallouzi I., Pelletier J. Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol. Biol. Cell 2006, 17(10):4212-4219.
160. McCartney S.A., Colonna M. Viral sensors: diversity in pathogen recognition. Immunol. Rev. 2009, 227(1):87-94.
161. Meehan A.M., Saenz D.T., Guevera R., Morrison J.H., Peretz M., Fadel H.J., Hamada M., van Deursen J., Poeschla E.M. A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathog. 2014, 10(2):e1003969.
162. Melen K., Keskinen P., Ronni T., Sareneva T., Lounatmaa K., Julkunen I. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J. Biol. Chem. 1996, 271(38):23478-23486.
163. Meng B., Lever A.M. Wrapping up the bad news: HIV assembly and release. Retrovirology 2013, 10:5.
164. Mervis R.J., Ahmad N., Lillehoj E.P., Raum M.G., Salazar F.H., Chan H.W., Venkatesan S. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 1988, 62(11):3993-4002.
165. Meurs E., Chong K., Galabru J., Thomas N.S., Kerr I.M., Williams B.R., Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990, 62(2):379-390.
166. Miller M.D., Farnet C.M., Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 1997, 71(7):5382-5390.
167. Misumi S., Inoue M., Dochi T., Kishimoto N., Hasegawa N., Takamune N., Shoji S. Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. J. Biol. Chem. 2010, 285(33):25185-25195.
168. Mohr D., Frey S., Fischer T., Guttler T., Gorlich D. Characterisation of the passive permeability barrier of nuclear pore complexes. EMBO J. 2009, 28(17):2541-2553.
169. Momany C., Kovari L.C., Prongay A.J., Keller W., Gitti R.K., Lee B.M., Gorbalenya A.E., Tong L., McClure J., Ehrlich L.S., Summers M.F., Carter C., Rossmann M.G. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 1996, 3(9):763-770.
170. Monaco-Malbet S., Berthet-Colominas C., Novelli A., Battai N., Piga N., Cheynet V., Mallet F., Cusack S. Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24. Structure 2000, 8(10):1069-1077.
171. Monette A., Ajamian L., Lopez-Lastra M., Mouland A.J. Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression. J. Biol. Chem. 2009, 284(45):31350-31362.
172. Monroe K.M., Yang Z., Johnson J.R., Geng X., Doitsh G., Krogan N.J., Greene W.C. IFI16 DNA sensor is required for death of lymphoid CD4T cells abortively infected with HIV. Science 2014, 343(6169):428-432.
173. Moore J.P., Kitchen S.G., Pugach P., Zack J.A. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20(1):111-126.
174. Morita E., Sundquist W.I. Retrovirus budding. Annu. Rev. Cell Dev. Biol. 2004, 20:395-425.
175. Nakayama E.E., Miyoshi H., Nagai Y., Shioda T. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J. Virol. 2005, 79(14):8870-8877.
176. Nakayama E.E., Nakajima T., Kaur G., Mimaya J.I., Terunuma H., Mehra N., Kimura A., Shioda T. A naturally occurring single amino acid substitution in human TRIM5alpha linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection. AIDS Res. Hum. Retroviruses 2013, 29(6):919-924.
177. Nisole S., Stoye J.P., Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3(10):799-808.
178. Norman J.P., Perry S.W., Kasischke K.A., Volsky D.J., Gelbard H.A. HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. J. Immunol. 2007, 178(2):869-876.
179. Ocwieja K.E., Brady T.L., Ronen K., Huegel A., Roth S.L., Schaller T., James L.C., Towers G.J., Young J.A., Chanda S.K., Konig R., Malani N., Berry C.C., Bushman F.D. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog. 2011, 7(3):e1001313.
180. Ohkura S., Yap M.W., Sheldon T., Stoye J.P. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J. Virol. 2006, 80(17):8554-8565.
181. Pace M.J., Agosto L., Graf E.H., O'Doherty U. HIV reservoirs and latency models. Virology 2011, 411(2):344-354.
182. Paine P.L., Moore L.C., Horowitz S.B. Nuclear envelope permeability. Nature 1975, 254(5496):109-114.
183. Pante N., Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39nm. Mol. Biol. Cell 2002, 13(2):425-434.
184. Pavlovic J., Zurcher T., Haller O., Staeheli P. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 1990, 64(7):3370-3375.
185. Pawlica P., Le Sage V., Poccardi N., Tremblay M.J., Mouland A.J., Berthoux L. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5alpha-mediated restriction of retroviruses. J. Virol. 2014, 88(10):5661-5676.
186. Perez-Caballero D., Hatziioannou T., Yang A., Cowan S., Bieniasz P.D. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J. Virol. 2005, 79(14):8969-8978.
187. Perron M.J., Stremlau M., Song B., Ulm W., Mulligan R.C., Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(32):11827-11832.
188. Pertel T., Hausmann S., Morger D., Zuger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A., Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M., Grutter M.G., Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472(7343):361-365.
189. Pham Q.T., Bouchard A., Grutter M.G., Berthoux L. Generation of human TRIM5alpha mutants with high HIV-1 restriction activity. Gene Ther. 2010, 17(7):859-871.
190. Pham Q.T., Veillette M., Brandariz-Nunez A., Pawlica P., Thibert-Lefebvre C., Chandonnet N., Diaz-Griffero F., Berthoux L. A novel aminoacid determinant of HIV-1 restriction in the TRIM5alpha variable 1 region isolated in a random mutagenic screen. Virus Res. 2013, 173(2):306-314.
191. Pornillos O., Ganser-Pornillos B.K., Kelly B.N., Hua Y., Whitby F.G., Stout C.D., Sundquist W.I., Hill C.P., Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137(7):1282-1292.
192. Pornillos O., Ganser-Pornillos B.K., Yeager M. Atomic-level modelling of the HIV capsid. Nature 2011, 469(7330):424-427.
193. Price A.J., Fletcher A.J., Schaller T., Elliott T., Lee K., KewalRamani V.N., Chin J.W., Towers G.J., James L.C. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 2012, 8(8):e1002896.
194. Rasaiyaah J., Tan C.P., Fletcher A.J., Price A.J., Blondeau C., Hilditch L., Jacques D.A., Selwood D.L., James L.C., Noursadeghi M., Towers G.J. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503(7476):402-405.
195. Rihn S.J., Wilson S.J., Loman N.J., Alim M., Bakker S.E., Bhella D., Gifford R.J., Rixon F.J., Bieniasz P.D. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog. 2013, 9(6):e1003461.
196. Rits M.A., van Dort K.A., Kootstra N.A. Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection. PLoS ONE 2008, 3(12):e3975.
197. Roa A., Hayashi F., Yang Y., Lienlaf M., Zhou J., Shi J., Watanabe S., Kigawa T., Yokoyama S., Aiken C., Diaz-Griffero F. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J. Virol. 2012, 86(3):1717-1727.
198. Roe T., Reynolds T.C., Yu G., Brown P.O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 1993, 12(5):2099-2108.
199. Schaller T., Ocwieja K.E., Rasaiyaah J., Price A.J., Brady T.L., Roth S.L., Hue S., Fletcher A.J., Lee K., KewalRamani V.N., Noursadeghi M., Jenner R.G., James L.C., Bushman F.D., Towers G.J. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011, 7(12):e1002439.
200. Sebastian S., Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
201. Shah S., Forbes D.J. Separate nuclear import pathways converge on the nucleoporin Nup153 and can be dissected with dominant-negative inhibitors. Curr. Biol. 1998, 8(25):1376-1386.
202. Shah V.B., Shi J., Hout D.R., Oztop I., Krishnan L., Ahn J., Shotwell M.S., Engelman A., Aiken C. The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating. J. Virol. 2013, 87(1):422-432.
203. Shen L., Siliciano R.F. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J. Allergy Clin. Immunol. 2008, 122(1):22-28.
204. Shi J., Zhou J., Shah V.B., Aiken C., Whitby K. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. J. Virol. 2011, 85(1):542-549.
205. Shin R., Tzou Y.M., Krishna N.R. Structure of a monomeric mutant of the HIV-1 capsid protein. Biochemistry 2011, 50(44):9457-9467.
206. Sokolskaja E., Sayah D.M., Luban J. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J. Virol. 2004, 78(23):12800-12808.
207. Song B., Javanbakht H., Perron M., Park D.H., Stremlau M., Sodroski J. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J. Virol. 2005, 79(7):3930-3937.
208. Song C., Aiken C. Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant. J. Virol. 2007, 81(21):11946-11956.
209. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
210. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(14):5514-5519.
211. Stremlau M., Perron M., Welikala S., Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J. Virol. 2005, 79(5):3139-3145.
212. Subbramanian R.A., Yao X.J., Dilhuydy H., Rougeau N., Bergeron D., Robitaille Y., Cohen E.A. Human immunodeficiency virus type 1 Vpr localization: nuclear transport of a viral protein modulated by a putative amphipathic helical structure and its relevance to biological activity. J. Mol. Biol. 1998, 278(1):13-30.
213. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339(6121):786-791.
214. Sundquist W.I., Krausslich H.G. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2(7):a006924.
215. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448(7152):501-505.
216. Tang C., Loeliger E., Kinde I., Kyere S., Mayo K., Barklis E., Sun Y., Huang M., Summers M.F. Antiviral inhibition of the HIV-1 capsid protein. J. Mol. Biol. 2003, 327(5):1013-1020.
217. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372(6504):363-365.
218. Ullman K.S., Shah S., Powers M.A., Forbes D.J. The nucleoporin nup153 plays a critical role in multiple types of nuclear export. Mol. Biol. Cell 1999, 10(3):649-664.
219. Unterholzner L. The interferon response to intracellular DNA: why so many receptors?. Immunobiology 2013, 218(11):1312-1321.
220. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.M., Jin T., Latz E., Xiao T.S., Fitzgerald K.A., Paludan S.R., Bowie A.G. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 2010, 11(11):997-1004.
221. Valiente-Echeverria F., Melnychuk L., Mouland A.J. Viral modulation of stress granules. Virus Res. 2012, 169(2):430-437.
222. Valiente-Echeverria F., Melnychuk L., Vyboh K., Ajamian L., Gallouzi I., Bernand N., Mouland A.J. eEF2 and Ras-GAP SH3 domain-binding protein modulate stress granule assembly during HIV-1 infection. Nat Comm. 2014, (in press). 10.1038/ncomms5819.
223. Valle-Casuso J.C., Di Nunzio F., Yang Y., Reszka N., Lienlaf M., Arhel N., Perez P., Brass A.L., Diaz-Griffero F. TNPO3 is required for HIV-1 replication after nuclear import but prior to integration and binds the HIV-1 core. J. Virol. 2012, 86(10):5931-5936.
224. Vatakis D.N., Nixon C.C., Zack J.A. Quiescent T cells and HIV: an unresolved relationship. Immunol. Res. 2010, 48(1-3):110-121.
225. Veronese F.D., Copeland T.D., Oroszlan S., Gallo R.C., Sarngadharan M.G. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J. Virol. 1988, 62(3):795-801.
226. Vozzolo L., Loh B., Gane P.J., Tribak M., Zhou L., Anderson I., Nyakatura E., Jenner R.G., Selwood D., Fassati A. Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. J. Biol. Chem. 2010, 285(50):39314-39328.
227. Wacharapornin P., Lauhakirti D., Auewarakul P. The effect of capsid mutations on HIV-1 uncoating. Virology 2007, 358(1):48-54.
228. Warrilow D., Meredith L., Davis A., Burrell C., Li P., Harrich D. Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro. J. Virol. 2008, 82(3):1425-1437.
229. Wente S.R., Rout M.P. The nuclear pore complex and nuclear transport. Cold Spring Harb. Perspect. Biol. 2010, 2(10):a000562.
230. Wilen C.B., Tilton J.C., Doms R.W. Molecular mechanisms of HIV entry. Adv. Exp. Med. Biol. 2012, 726:223-242.
231. Worthylake D.K., Wang H., Yoo S., Sundquist W.I., Hill C.P. Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr. D: Biol. Crystallogr. 1999, 55(Pt 1):85-92.
232. Xu H., Franks T., Gibson G., Huber K., Rahm N., De Castillia C.S., Luban J., Aiken C., Watkins S., Sluis-Cremer N., Ambrose Z. Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay. Retrovirology 2013, 10:70.
233. Yamashita M., Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. J. Virol. 2004, 78(11):5670-5678.
234. Yamashita M., Emerman M. Retroviral infection of non-dividing cells: old and new perspectives. Virology 2006, 344(1):88-93.
235. Yamashita M., Emerman M. Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells. J. Virol. 2009, 83(19):9835-9843.
236. Yamashita M., Perez O., Hope T.J., Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog. 2007, 3(10):1502-1510.
237. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 2010, 11(11):1005-1013.
238. Yang H., Ji X., Zhao G., Ning J., Zhao Q., Aiken C., Gronenborn A.M., Zhang P., Xiong Y. Structural insight into HIV-1 capsid recognition by rhesus TRIM5alpha. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(45):18372-18377.
239. Yang P., An H., Liu X., Wen M., Zheng Y., Rui Y., Cao X. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat. Immunol. 2010, 11(6):487-494.
240. Yang R., Aiken C. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. J. Virol. 2007, 81(8):3749-3756.
241. Yao X.J., Subbramanian R.A., Rougeau N., Boisvert F., Bergeron D., Cohen E.A. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 1995, 69(11):7032-7044.
242. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(29):10786-10791.
243. Yap M.W., Nisole S., Stoye J.P. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction. Curr. Biol. 2005, 15(1):73-78.
244. Yin L., Boussard S., Allan J., Luban J. The HIV type 1 replication block in nonhuman primates is not explained by differences in cyclophilin A primary structure. AIDS Res. Hum. Retroviruses 1998, 14(1):95-97.
245. Yin L., Braaten D., Luban J. Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels. J. Virol. 1998, 72(8):6430-6436.
246. Ylinen L.M., Schaller T., Price A., Fletcher A.J., Noursadeghi M., James L.C., Towers G.J. Cyclophilin A levels dictate infection efficiency of human immunodeficiency virus type 1 capsid escape mutants A92E and G94D. J. Virol. 2009, 83(4):2044-2047.
247. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 2004, 5(7):730-737.
248. Yufenyuy E.L., Aiken C. The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid. Retrovirology 2013, 10:29.
249. Zaitseva L., Cherepanov P., Leyens L., Wilson S.J., Rasaiyaah J., Fassati A. HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology 2009, 6:11.
250. Zennou V., Petit C., Guetard D., Nerhbass U., Montagnier L., Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101(2):173-185.
251. Zhang R., Mehla R., Chauhan A. Perturbation of host nuclear membrane component RanBP2 impairs the nuclear import of human immunodeficiency virus-1 preintegration complex (DNA). PLoS ONE 2010, 5(12):e15620.
252. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 2011, 12(10):959-965.
253. Zhao G., Perilla J.R., Yufenyuy E.L., Meng X., Chen B., Ning J., Ahn J., Gronenborn A.M., Schulten K., Aiken C., Zhang P. Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics. Nature 2013, 497(7451):643-646.
254. Zhou L., Sokolskaja E., Jolly C., James W., Cowley S.A., Fassati A. Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathog. 2011, 7(8):e1002194.